Breaking News
Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9,306.000 +170.500    +1.87%
27/03 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 1,487
  • Bid/Ask: 9,246.000 / 9,342.000
  • Day's Range: 9,171.000 - 9,311.500
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110665 
Amgen 9,306.000 +170.500 +1.87%

AMGN Balance Sheet

 
Featured here, the Balance Sheet for Amgen Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/12
2022
30/09
2022
30/06
2022
31/03
Total Current Assets 22186 24062 19322 18520
Cash and Short Term Investments 9305 11478 7183 6544
Cash - - - -
Cash & Equivalents 7629 9502 5203 6528
Short Term Investments 1676 1976 1980 16
Total Receivables, Net 6392 5326 5327 5077
Accounts Receivables - Trade, Net 5563 5326 5327 5077
Total Inventory 4930 4757 4554 4411
Prepaid Expenses 1204 - - -
Other Current Assets, Total 355 2501 2258 2488
Total Assets 65121 63700 59294 59196
Property/Plant/Equipment, Total - Net 6006 5188 5158 5142
Property/Plant/Equipment, Total - Gross 15289 14388 14158 14042
Accumulated Depreciation, Total -9283 -9200 -9000 -8900
Goodwill, Net 15529 14845 14865 14897
Intangibles, Net 16080 13266 13927 14567
Long Term Investments 3162 874 979 1137
Note Receivable - Long Term 829 - - -
Other Long Term Assets, Total 2158 5465 5043 4933
Other Assets, Total 569 3908 3465 1838
Total Current Liabilities 15687 14331 12618 12886
Accounts Payable 1572 1204 1256 1403
Payable/Accrued - - - -
Accrued Expenses 9488 11584 10545 10639
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1747 1543 817 844
Other Current liabilities, Total 2880 - - -
Total Liabilities 61460 60047 56875 58280
Total Long Term Debt 37354 37161 35705 36010
Long Term Debt 37354 37161 35705 36010
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 8419 8555 8552 9384
Total Equity 3661 3653 2419 916
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 32514 32371 31343 31247
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) -28622 -28066 -28252 -29568
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -231 -652 -672 -763
Total Liabilities & Shareholders' Equity 65121 63700 59294 59196
Total Common Shares Outstanding 534 533.5 534.9 534.2
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMGN Comments

Write your thoughts about Amgen
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email